David Bourdon - Oct 1, 2021 Form 4 Insider Report for MAGELLAN HEALTH INC (MGLN)

Role: Chief Financial Officer
Signature: /s/ David Bourdon
Stock symbol: MGLN
Transactions as of: Oct 1, 2021
Transactions value $: -$81,614
Form type: 4
Date filed: 10/5/2021, 07:11 PM
Next filing: Jan 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGLN	Ordinary Common Stock, $0.01 par value	Options Exercise	$0	+2.19K		$0.00	2.19K	Oct 1, 2021	Direct	F1, F2
transaction	MGLN	Ordinary Common Stock, $0.01 par value	Tax liability	-$81.6K	-862	-39.32%	$94.68	1.33K	Oct 1, 2021	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGLN	Restricted Stock Units	Options Exercise	$0	-2.19K	-33.34%	$0.00	4.38K	Oct 1, 2021	Common Stock	2.19K	$0.00	Direct	F1, F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on October 1, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
F2	Not applicable.
F3	Represents the portion of shares withheld by the Company in order to pay taxes.
F4	Closing price on NASDAQ on October 1, 2021.
F5	The remainder of 4,383 Restricted Stock Units shall vest in equal increments on October 1, 2022 and 2023, subject to earlier acceleration or forfeiture.